Tamoxifen treatment for advanced renal cell cancer.
Twelve patients with metastatic clear cell renal cancer received a course of tamoxifen. Three showed stable disease for a period from 2 to 12 months and 1 a mixed response for a short time. It does not appear that tamoxifen may be a useful agent in the treatment of metastatic renal cell carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000368:Aged; D001859:Bone Neoplasms; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008175:Lung Neoplasms; D008207:Lymphatic Metastasis; D008297:Male; D008479:Mediastinal Neoplasms; D008875:Middle Aged; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen